|Kathryn King||SVP of Clinical and CMC operations|
|Harald Murck||VP of Medical and Clinical Affairs|
|Charles Duncan||Cantor Fitzgerald|
|Myles Minter||William Blair|
Good afternoon, and welcome to the Aptinyx First Quarter 2022 Financial Results Conference Call. [Operator Instructions] Please be advised the call is being recorded at the company's request. At this time, I would like to turn the call over to Pat Flavin, Senior Manager of Corporate Development and Investor Relations at Aptinyx. Pat, please proceed.
Good afternoon, everyone, and thank you for joining us on today's conference call to discuss Aptinyx' first quarter 2022 financial and operating results.